SIC
NMTR

Sterling Investment Counsel’s 9 Meters Biopharma NMTR Stock Holding History

Sterling Investment Counsel’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-877
Closed -$11K – 162
2022
Q1 		$11K Buy
877
+250
+40% +$3.41K 0.01% 147
2021
Q4 		$12K Buy
+627
New +$14K 0.01% 141

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWM
Curi Wealth Management Raleigh, North Carolina $724M AUM 17.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Sterling Investment Counsel's NMTR Position: Q2 2022 in Review

Sterling Investment Counsel sold out of 9 Meters Biopharma (NMTR) in Q2 2022, closing a stake of 877 shares — an estimated $11K sold.

Sterling Investment Counsel first reported a position in NMTR in Q4 2021 and held it in 2 quarters. The position peaked at $12K in Q4 2021. 88 funds tracked by Wall St. Rank hold NMTR as of Q2 2022.

  • Sterling Investment Counsel reported no remaining 9 Meters Biopharma position as of Q2 2022 after selling out during the quarter.
  • Sterling Investment Counsel sold 877 9 Meters Biopharma shares in Q2 2022, an estimated $11K.
  • Sterling Investment Counsel first reported a position in 9 Meters Biopharma in Q4 2021 and held it in 2 quarters.
  • Sterling Investment Counsel's 9 Meters Biopharma position peaked at $12K in Q4 2021.
  • 88 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2022.

Based on Sterling Investment Counsel's 13F filing for Q2 2022, filed 18 Jul 2022.